a method for treating type ii diabetes by administering to an affected individual a combination of chromic tripicolinate and biotin at doses far beyond the nutritional requirements . the two compounds are administered orally or parenterally at in daily dosages which provide between 1 , 000 and 10 , 000 μg of chromium and between 1 mg and 200 mg biotin .